{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:56:57Z","timestamp":1791341817907,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.tibtech.2008.06.007","type":"journal-article","created":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T05:28:50Z","timestamp":1219382930000},"page":"552-558","source":"Crossref","is-referenced-by-count":300,"title":["Does a targeting ligand influence nanoparticle tumor localization or uptake?"],"prefix":"10.1016","volume":"26","author":[{"given":"Kathleen F.","family":"Pirollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2008.06.007_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1261\/rna.459807","article-title":"Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting","volume":"13","author":"De Paula","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.tibtech.2008.06.007_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/hum.2006.17.1062","article-title":"Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer","volume":"17","author":"Meyer","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-viral gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tibtech.2008.06.007_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of pegylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.tibtech.2008.06.007_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tibtech.2008.06.007_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/187152006778699121","article-title":"Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer","volume":"6","author":"Allen","year":"2006","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.tibtech.2008.06.007_bib8","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.2174\/138161206779026272","article-title":"Exploiting EPR in polymer drug conjugate delivery for tumor targeting","volume":"12","author":"Modi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tibtech.2008.06.007_bib9","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tibtech.2008.06.007_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.tibtech.2008.06.007_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/187152007781668706","article-title":"Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers","volume":"7","author":"Garanger","year":"2007","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.tibtech.2008.06.007_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.mt.6300176","article-title":"Cellular dynamics of EGF receptor-targeted synthetic viruses","volume":"15","author":"de Bruin","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib14","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20457","article-title":"Folate receptor-mediated drug targeting: from therapeutics to diagnostics","volume":"94","author":"Hilgenbrink","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tibtech.2008.06.007_bib15","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1089\/10430349950016357","article-title":"Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts","volume":"10","author":"Xu","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tibtech.2008.06.007_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2006.04.009","article-title":"Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability","volume":"113","author":"Dass","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.tibtech.2008.06.007_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF03401962","article-title":"Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv","volume":"7","author":"Xu","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.tibtech.2008.06.007_bib19","first-page":"337","article-title":"Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes","volume":"1","author":"Xu","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/hum.2006.17.117","article-title":"Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery","volume":"17","author":"Pirollo","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib21","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1158\/0008-5472.CAN-06-4535","article-title":"Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system","volume":"67","author":"Pirollo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib22","series-title":"Vector Targeting for Therapeutic Gene Delivery","first-page":"33","article-title":"Immunoliposomes: a targeted delivery tool for cancer treatment","author":"Pirollo","year":"2002"},{"key":"10.1016\/j.tibtech.2008.06.007_bib23","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2008.06.007_bib24","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib25","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1073\/pnas.150228297","article-title":"High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment","volume":"97","author":"Wu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2008.06.007_bib26","first-page":"1962","article-title":"124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice","volume":"44","author":"Sundaresan","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tibtech.2008.06.007_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.gt.3301351","article-title":"Polyethylenimine\/DNA complexes shielded by transferrin target gene expression to tumors after systemic application","volume":"8","author":"Kircheis","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib28","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/nar\/gnh049","article-title":"Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide","volume":"32","author":"Yu","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.tibtech.2008.06.007_bib30","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1158\/1535-7163.MCT-07-0615","article-title":"Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system","volume":"6","author":"Hussain","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4161\/cbt.3.7.918","article-title":"Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles","volume":"3","author":"Pun","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(07)70274-7","article-title":"Non-[18F]FDG PET in clinical oncology","volume":"8","author":"Groves","year":"2007","journal-title":"Lancet Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.tibtech.2008.06.007_bib33","first-page":"36S","article-title":"Monitoring cancer treatment with PET\/CT: does it make a difference?","volume":"48","author":"Weber","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tibtech.2008.06.007_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1078\/0939-3889-00288","article-title":"Recent developments and future trends in nuclear medicine instrumentation","volume":"16","author":"Zaidi","year":"2006","journal-title":"Z. Med. Phys."},{"key":"10.1016\/j.tibtech.2008.06.007_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2967\/jnumed.107.045302","article-title":"In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium","volume":"49","author":"Rossin","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tibtech.2008.06.007_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","article-title":"Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications","volume":"3","author":"Maeda","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tibtech.2008.06.007_bib37","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-4328","article-title":"The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas","volume":"66","author":"Cao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11095-006-9662-5","article-title":"Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors","volume":"23","author":"Khalid","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tibtech.2008.06.007_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-\u03b1-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tibtech.2008.06.007_bib40","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.gt.3302304","article-title":"A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene","volume":"11","author":"Yu","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2008.06.007_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/08982100600848769","article-title":"Pros and cons of the liposome platform in cancer drug targeting","volume":"16","author":"Gabizon","year":"2006","journal-title":"J. Liposome Res."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779908001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779908001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:34:02Z","timestamp":1557743642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779908001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0167779908001947"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2008.06.007","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}